// STATE LEGISLATION TRACKER

Ohio HB 775 — Regards state agencies' authority to adopt administrative rules

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Ohio
Bill: HB 775
Session: 136
Filed: 2026-03-24
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Ohio HB775 appears to be a broad administrative-rules bill about state agencies' power to adopt rules, not a peptide-specific health care bill. Based on the title, subjects, and lack of recorded actions, it does not directly affect compounded peptides, prescribing, telehealth, clinician scope, FDA compounding, controlled substances, or prescription monitoring.

Key Points

No direct peptide access change is apparent from the title or subjects
No specific effect on compounded peptides can be inferred
No clear change to NP, naturopathic, or telehealth practice is shown
No controlled-substance or prescription-monitoring issue is apparent

What to Watch For

Note Watch for bill text or amendments that name health boards, pharmacy rules, or prescribing rules.

Note If it limits agency rulemaking broadly, health-care regulators could be affected indirectly.

Note No recorded actions means there is not enough process history to judge momentum.

Where the Bill Stands

The source lists no recorded actions, so the bill's procedural status cannot be confirmed from the available information.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws